Dis3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers

Sophie R. Robinson, Sandra C. Viegas, Rute G. Matos, Susana Domingues, Marisa Bedir, Helen J.S. Stewart, Timothy J. Chevassut, Antony W. Oliver, Cecilia M. Arraiano, Sarah F. Newbury

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

DIS3 (defective in sister chromatid joining) is the catalytic subunit of the exosome, a protein complex involved in the 30–50 degradation of RNAs. DIS3 is a highly conserved exoribonuclease, also known as Rrp44. Global sequencing studies have identified DIS3 as being mutated in a range of cancers, with a considerable incidence in multiple myeloma. In this work, we have identified two protein-coding isoforms of DIS3. Both isoforms are functionally relevant and result from alternative splicing. They differ from each other in the size of their N-terminal PIN (PilT N-terminal) domain, which has been shown to have endoribonuclease activity and tether DIS3 to the exosome. Isoform 1 encodes a full-length PIN domain, whereas the PIN domain of isoform 2 is shorter and is missing a segment with conserved amino acids. We have carried out biochemical activity assays on both isoforms of full-length DIS3 and the isolated PIN domains. We find that isoform 2, despite missing part of the PIN domain, has greater endonuclease activity compared with isoform 1. Examination of the available structural information allows us to provide a hypothesis to explain this altered behaviour. Our results also show that multiple myeloma patient cells and all cancer cell lines tested have higher levels of isoform 1 compared with isoform 2, whereas acute myeloid leukaemia and chronic myelomonocytic leukaemia patient cells and samples from healthy donors have similar levels of isoforms 1 and 2. Taken together, our data indicate that significant changes in the ratios of the two isoforms could be symptomatic of haematological cancers.

Original languageEnglish
Pages (from-to)2091-2105
Number of pages15
JournalBiochemical Journal
Volume475
Issue number12
DOIs
Publication statusPublished - 29 Jun 2018

Fingerprint Dive into the research topics of 'Dis3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers'. Together they form a unique fingerprint.

  • Cite this

    Robinson, S. R., Viegas, S. C., Matos, R. G., Domingues, S., Bedir, M., Stewart, H. J. S., Chevassut, T. J., Oliver, A. W., Arraiano, C. M., & Newbury, S. F. (2018). Dis3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers. Biochemical Journal, 475(12), 2091-2105. https://doi.org/10.1042/BCJ20170962